Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.60 |
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.53 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.52 |
| ▸ | RELA | Q04206 | 4/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12951398 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL27591402 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL27856043 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL18721508 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL12085671 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL18721509 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL194526 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL194531 | 0.94 | SLC6A5 (0.68) | CASP2SLC6A5NAAAPAOXRELA | |
| SCHEMBL15065767 | 0.92 | SLC6A5 (0.70) | CASP2SLC6A5NAAAPAOXFAAH | |
| SCHEMBL15065083 | 0.92 | SLC6A5 (0.70) | CASP2SLC6A5NAAAPAOXFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170119643-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | THE PROCTER & GAMBLE COMPANY | 2017-05-04 | — | — | US | disclosed |
| US-20170119643-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | THE PROCTER & GAMBLE COMPANY | 2017-05-04 | — | — | US | disclosed |
| WO-2016179561-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | THE PROCTER & GAMBLE COMPANY (US) | 2016-11-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170119643-A1 | DETOXIFICATION OF MICROBIAL VIRULENCE FACTORS IN ORAL CAVITY | GSTM2, GSTA2, GSTA1 | CASP2 2644/4885SLC6A5 2044/4885NAAA 853/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.